My practice focuses on patent disputes before district courts, the ITC and the PTAB. I began practicing in 2011 and have had the opportunity to work on cases involving a variety of technologies.
New addition brings a "wealth" of patent litigation experience to the role | Successful candidate has a strong background in global IP policy and diversity initiatives.
A look back at the highlights of May 2021
Journeys of Innovation
The co-founders of Kinnos, Kevin Tyan, Jason Kang, and Katherine Jin, learned from healthcare workers and developed a life-saving additive for disinfectants.
Innovating to fight Ebola
Motivated by Columbia University s 2014 Design Challenge to fight Ebola, Jason Kang, Katherine Jin, and Kevin Tyan created Highlight, an additive that temporarily colors disinfectants made with bleach so users can confirm they ve properly treated a contaminated surface. The trio founded Kinnos to develop and market their product, and they re now firmly establishing themselves in the world of infection prevention. Looking back on their success so far, Kang, Jin, and Tyan credit healthcare workers for important lessons learned, not only about their product, but also about what it really means to make a difference.
10X Genomics challenged claims in Bio-Rad’s U.S. Pat. No. 9,562,837 and 9,896,722. The PTAB issued four mixed Final Written Decisions in 10X Genomics Inc. v. Bio-Rad Labs., Inc., IPR2020-00086, -00087, -00088, and -00089, finding most claims unpatentable but allowing a few to survive.